Related Experiment Video
Updated: May 20, 2026
05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Future perspectives of prostate cancer therapy
Murali Gururajan1, Edwin M Posadas, Leland W K Chung
1Uro-Oncology Research Program, Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Translational Andrology and Urology
|July 10, 2012
Summary
Recent advances in prostate cancer therapy focus on immunotherapy by targeting the tumor microenvironment. This approach aims to improve treatments for bone and soft tissue metastases, offering new hope beyond traditional chemotherapy.
Area of Science:
- Oncology
- Immunology
- Cancer Biology
Background:
- Prostate cancer treatment faces challenges with tumor-stroma-immune cell microenvironment interactions.
- Emerging research highlights the critical role of immune cells in the tumor microenvironment.
- Immunotherapy is gaining traction for prostate cancer treatment.
Purpose of the Study:
- To review recent laboratory advances in understanding and manipulating the tumor microenvironment for prostate cancer therapy.
- To explore novel therapeutic strategies for improving outcomes in prostate cancer patients with bone and soft tissue metastases.
- To discuss the potential of immunotherapy to complement or replace traditional chemotherapy.
Main Methods:
- Review of recent laboratory findings on tumor-stroma-immune cell interactions.
- Analysis of successes and failures in prostate cancer immunotherapy trials.
- Examination of factors within the tumor microenvironment that can be targeted.
Main Results:
- Improved understanding of immune cell roles in the prostate cancer microenvironment.
- FDA approval of an immunotherapeutic drug signifies progress.
- Recognition of immunotherapy's potential in solid tumors, including prostate cancer.
Conclusions:
- The field of tumor immunology is poised for significant growth in prostate cancer research.
- New immunomodulatory drugs are anticipated to enhance or replace conventional chemotherapeutics.
- Future research should focus on leveraging the tumor microenvironment for therapeutic benefit.
More Related Videos
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...